Mr. Nimrod Bin-Nun has an extensive experience in global Pharma, Medical Devices and Diagnostics companies. Prior to his CEO position in DiagnosTear Mr. Bin-Nun worked in BioLight as a business development director, leading the business development activity of the group and supporting BioLight portfolio companies.
Previously, Mr. Bin-Nun worked at Teva Pharmaceuticals for 6 years in both finance and business development, mostly focusing on the Asian markets.
Nimrod holds a dual-BA/B.Sc. in Economics and Biology and an MBA in Finance and Marketing, both from Tel Aviv University.